Ireland - Financial Media Contact
Powerscourt
Tel: +353 (0)1 536 0682
2025 AGM Voting
RNS Announcements
Investee Companies
Tue, 08 Apr 2025
Holding(s) in Company
Mon, 07 Apr 2025
Director/PDMR Shareholding - Replacement
Director/PDMR Shareholding
News Archive>
11 Dec 2024
Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting
07 Nov 2024
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
24 Oct 2024
Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema
17 Oct 2024
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche
27 Sep 2024
Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients
